Vista Investment Partners II’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
11,414
+96
+0.8% +$98.1K 5.37% 1
2026
Q1
$10.4M Sell
11,318
-80
-0.7% -$81.1K 4.67% 1
2025
Q4
$12.2M Sell
11,398
-102
-0.9% -$97.5K 5.28% 1
2025
Q3
$8.77M Buy
11,500
+20
+0.2% +$14.9K 4.09% 2
2025
Q2
$8.95M Sell
11,480
-63
-0.5% -$49K 4.32% 2
2025
Q1
$9.53M Buy
11,543
+82
+0.7% +$68.2K 5.27% 2
2024
Q4
$8.85M Buy
+11,461
New +$9.49M 5.22% 1

Other funds holding LLY

Vista Investment Partners II's LLY Position: Q2 2026 in Review

Vista Investment Partners II increased its Eli Lilly (LLY) stake by 0.85% in Q2 2026, buying an estimated $98.1K and bringing the position to 11,414 shares worth $13.7M. The position accounts for 5.37% of the portfolio, ranked #1.

Vista Investment Partners II first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,920 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vista Investment Partners II held 11,414 shares of Eli Lilly worth $13.7M as of Q2 2026.
  • Vista Investment Partners II bought 96 Eli Lilly shares in Q2 2026, an estimated $98.1K.
  • Eli Lilly made up 5.37% of Vista Investment Partners II's portfolio in Q2 2026, its #1 holding.
  • Vista Investment Partners II first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,920 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vista Investment Partners II's 13F filing for Q2 2026, filed 21 Jul 2026.